Literature DB >> 17584686

Repolarization abnormalities and arrhythmogenesis in hypertrophic myocardium.

Luigi De Ambroggi1, Pietro Francia, Guido De Ambroggi.   

Abstract

Left ventricular hypertrophy (LVH) is accompanied by specific changes of the cellular electrophysiology, which are potentially arrhythmogenic, mainly prolongation of action potential duration due to down-regulation of several K channels. Moreover, transmural dispersion of repolarization due to presence of cell types with different repolarization properties within the ventricular wall plays an essential role in the development of transmural functional reentry responsible for the maintenance of ventricular tachycardia (VT), once it has been initiated. Experimental evidence has been provided that phase 2 early afterdepolarizations (EAD) can be generated from hypertrophied left ventricular wall in the absence of action potential duration (APD) prolonging agents. Phase 2 EADs could be associated with malignant "R on T" extrasystoles, initiating polymorphic VT. Unfortunately, the abnormalities of ventricular repolarization are not always revealed on surface electrocardiogram (ECG) and when present they have a low predictive power for occurrence of life-threatening arrhythmias and sudden cardiac death. In order to reveal signs of repolarization heterogeneities not apparent from 12-lead ECG analysis, we studied body surface potential maps in a group of patients with LVH due to valvular aortic stenosis. The similarity index was significantly lower and the late repolarization deviation index was significantly higher in patients than in normal subjects. These findings suggested a higher than normal degree of heterogeneities of repolarization in LVH patients, not detected by the usual ECG analysis.

Entities:  

Mesh:

Year:  2007        PMID: 17584686

Source DB:  PubMed          Journal:  Anadolu Kardiyol Derg        ISSN: 1302-8723


  7 in total

Review 1.  The Impending Dilemma of Electrocardiogram Screening in Athletic Children.

Authors:  Laure Léger; Boris Gojanovic; Nicole Sekarski; Erik J Meijboom; Yvan Mivelaz
Journal:  Pediatr Cardiol       Date:  2015-08-20       Impact factor: 1.655

2.  The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle.

Authors:  Lin Piao; Yong-Hu Fang; Virgilio J J Cadete; Christian Wietholt; Dalia Urboniene; Peter T Toth; Glenn Marsboom; Hannah J Zhang; Idith Haber; Jalees Rehman; Gary D Lopaschuk; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2009-12-01       Impact factor: 4.599

Review 3.  Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice.

Authors:  Yaniel Castro-Torres; Raimundo Carmona-Puerta; Richard E Katholi
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

4.  Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner.

Authors:  Jonah M Graves; Julian A Vallejo; Chelsea S Hamill; Derek Wang; Rohan Ahuja; Shaan Patel; Christian Faul; Michael J Wacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-30       Impact factor: 5.125

5.  Influence of left ventricular type on QT interval in hypertensive patients.

Authors:  Ragesh Panikkath; Deepa Panikkath
Journal:  Anatol J Cardiol       Date:  2014-12-25       Impact factor: 1.596

6.  Implantable Cardioverter-defibrillator Therapy for Syncope: An Educational Example of a Multicomponent Electrocardiographic Differential Diagnosis and the Application of Clinical Trial Data to an Individual Patient.

Authors:  Daniel N Pugliese; James A Reiffel
Journal:  J Innov Card Rhythm Manag       Date:  2019-10-15

Review 7.  Acquired long QT syndrome in chronic kidney disease patients.

Authors:  Peng Liu; Lu Wang; Dan Han; Chaofeng Sun; Xiaolin Xue; Guoliang Li
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.